Donor-recipient mismatches in MHC class I chain-related gene a in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

Blood

Volumn 114, Issue 14, 2009, Pages 2884-2887

  Parmar, Simrit ^a   De Lima, Marcos ^a   Zou, Yizhou ^b   Patah, Poliana A ^c   Liu, Ping ^a   Cano, Pedro ^a   Rondon, Gabriela ^a   Pesoa, Susana ^a   De Padua Silva, Leandro ^a   Qazilbash, Muzaffar H ^a   Hosing, Chitra ^a   Popat, Uday ^a   Kebriaei, Partow ^a   Shpall, Elizabeth J ^a   Giralt, Sergio ^a   Champlin, Richard E ^a   Stastny, Peter ^b   Fernandez Vina, Marcelo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CLOFARABINE; CYCLOPHOSPHAMIDE; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELPHALAN; METHOTREXATE; PENTOSTATIN; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; GASTROINTESTINAL SYMPTOM; GENE ACTIVATION; GENE LOCUS; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HLA MATCHING; HLA SYSTEM; HOST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; FEMALE; GENES, MHC CLASS I; GENOTYPE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70449490046     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-223172     Document Type: Article

References (25)

1. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7):1923-1930. (Pubitemid 39297840)
2. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A. 1994;91(14):6259-6263. (Pubitemid 24200639)
3. Lucas D, Campillo JA, Lopez-Hernandez R, et al. Allelic diversity of MICA gene and MICA/HLA-B haplotypic variation in a population of the Murcia region in southeastern Spain. Hum Immunol. 2008;69(10):655-660.
4. Jinushi M, Takehara T, Kanto T, et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol. 2003;170(3):1249-1256. (Pubitemid 36139490)
5. Tieng V, Le Bouguenec C, du Merle L, et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A. 2002;99(5):2977-2982. (Pubitemid 34240571)
6. Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol. 2000;61(9):917-924. (Pubitemid 30797916)
7. Mizutani K, Terasaki PI, Shih RN, Pei R, Ozawa M, Lee J. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol. 2006;67(3):223-229. (Pubitemid 43673928)
8. Gannage M, Buzyn A, Bogiatzi SI, et al. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease. Transplantation. 2008;85(6):911-915.
9. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol. 2001;2(3):255-260. (Pubitemid 33706003)
10. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996;93(22):12445- 12450. (Pubitemid 26367163)
11. Zou Y, Stastny P, Susal C, Dohler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med. 2007;357(13):1293-1300. (Pubitemid 47481451)
12. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol. 2003;4(2):154-160. (Pubitemid 36193017)
13. de Lima M, Couriel D, Thall PF, et al. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood. 2004;104(3):857-864. (Pubitemid 38970585)
14. de Padua Silva L, Anderson BS, Popat U, et al. Treatment of AML in first remission (CR1) with allogeneic hematopoietic stem cell transplantation (HSCT) using unrelated donors (UD). Blood (ASH Annual Meeting Abstracts). 2008;112:Abstract 976.
15. Zou Y, Han M, Wang Z, Stastny P. MICA allele-level typing by sequence-based typing with computerized assignment of polymorphic sites and short tandem repeats within the transmembrane region. Hum Immunol. 2006;67(3):145-151. (Pubitemid 43673919)
16. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825-828.
17. Kaplan MMP. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457-481.
18. Cox D. Regression models and life tables. J R Statist Soc B. 1972;34:187-220.
19. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
20. Petersdorf EW, Shuler KB, Longton GM, Spies T, Hansen JA. Population study of allelic diversity in the human MHC class I-related MIC-A gene. Immunogenetics. 1999;49(7):605-612. (Pubitemid 29278446)
21. Zhang Y, Lazaro AM, Lavingia B, Stastny P. Typing for all known MICA alleles by group-specific PCR and SSOP. Hum Immunol. 2001;62(6):620-631. (Pubitemid 32506180)
22. Zou Y, Qin Z, Silveus A, Fan Y, Stastny P. Polymorphisms of MICA recognized by human alloantibodies. Immunogenetics. 2009;61(2):91-100.
23. Malkki M, Gooley TA, Horowitz MM, et al. Mapping MHC-resident transplantation determinants. Biol Blood Marrow Transplant. 2007;13(8):986-995.
24. Kitcharoen K, Witt CS, Romphruk AV, Christiansen FT, Leelayuwat C. MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome. Hum Immunol. 2006;67(3):238-246. (Pubitemid 43673923)
25. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 2007;4(1):e8. (Pubitemid 46191822)